Market Value212,490,000
Total Holdings61
File Date2015-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BIO / Bio-Rad Laboratories, Inc.
CPHD / Cepheid
PETX / Aratana Therapeutics, Inc.
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
US74975N1054 / RTI Surgical, Inc.
ENDP / Endo International plc
CYH / Community Health Systems, Inc.
AKRX / Akorn, Inc.
/ Oxford Immunotec Global PLC
LGND / Ligand Pharmaceuticals Incorporated
ESPR / Esperion Therapeutics, Inc.
MRK / Merck & Co., Inc.
018490100 / Allergan plc
US29266S3040 / Endologix, Inc.
STRM / Streamline Health Solutions, Inc.
878193101 / TearLab Corp
STAA / STAAR Surgical Company
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
ANGO / AngioDynamics, Inc.
LCI / Lannett Co., Inc.
HBIO / Harvard Bioscience, Inc.
HSTM / HealthStream, Inc.
CYNA / Cynapsus Therapeutics Inc.
449575AB5 / Igi Laboratories Inc Bond
MYGN / Myriad Genetics, Inc.
G0083B108 / Actavis
US00163U1060 / AMAG Pharmaceuticals, Inc.
NXTM / NxStage Medical, Inc.
LMAT / LeMaitre Vascular, Inc.
AET / Aetna, Inc.
AMGN / Amgen Inc.
STKL / SunOpta Inc.
A / Agilent Technologies, Inc.
SPNC / Spectranetics Corp. (The)
LHCG / LHC Group Inc
FLDM / Standard BioTools Inc
VRTX / Vertex Pharmaceuticals Incorporated
SNY / Sanofi - Depositary Receipt (Common Stock)
JNJ / Johnson & Johnson
UTHR / United Therapeutics Corporation
CYTK / Cytokinetics, Incorporated
LLY / Eli Lilly and Company
STJ / St. Jude Medical, Inc.
QDEL / QuidelOrtho Corporation
CLDX / Celldex Therapeutics, Inc.
US00C4U1L353 / Mylan N.V.
/ Array BioPharma, Inc.
BMY / Bristol-Myers Squibb Company
VSTM / Verastem, Inc.
PFE / Pfizer Inc.
STE / STERIS plc
CELG / Celgene Corp.
BDX / Becton, Dickinson and Company
TECH / Bio-Techne Corporation
HUM / Humana Inc.
BLUE / bluebird bio, Inc.
INSM / Insmed Incorporated
VCYT / Veracyte, Inc.
BMRN / BioMarin Pharmaceutical Inc.
ALKS / Alkermes plc
ENZ / Enzo Biochem, Inc.
NEO / NeoGenomics, Inc.
ELV / Elevance Health, Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
ATRC / AtriCure, Inc.
OMCL / Omnicell, Inc.